1Aldrich D, Hunt DP. When can the patient with deep venous thrombosis begin to ambulate? Phys Ther,2004 ,84 :268-273.
2American Thoracic Society, American College of Chest Physicians.ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med ,2003,167 : 211-277.
3Ambrosetti M, Salerno M, Ageno W, et al. Is physical training contraindicated in patients with deep vein thrombosis during cardiac rehabilitation?Monaldi Arch Chest Dis ,2005,64:24-26.
5Monchamp T, Frishnam WH. Exercise as a treatment modality for congestive heart failure. Heart Dis ,2002,4 : 110-116.
6Hambrecht R, Adams V, Gielen S, et al. Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol , 1999,33 : 174-179.
7Braith RW, Welsch MA, Feigenbaum MS, et al. Neuroendocrine activation in heart failure is modified by endurance exercise training.J Am Coll Cardio , 1999,34 : 1170-1175.
8Glodhaber SZ, Elliott CG. Acute pulmonary embolism: part Ⅰ:epidemiology, pathophysiology, and diagnosis. Circulation, 2003,108:2726-2729.
9Vidal Melo MF, Harris RS, Layfield D, et al. Changes in regional ventilation after autologous blood clot pulmonary embolism.Anesthesiology, 2002,97 : 671-681.
10Spruit MA,Troosters T, Trappenburg JC, et al. Exercise training during rehabilitation of patients with COPD: a current perspective.Patient Educ Courts, 2004,52:243-248.
6Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrnmbolytic Therapy [ J]. Chest, 2004, 126 (3 Suppl) :401S -428S.
7Wan S, Quinlan DJ, Agnelli G, et al. Thrombolysis compared with heparin for the inititial treatment of pulmonary embolism: a metaanalysis of the randomised controlled trials [ J ]. Circulation, 2004, 110(6) :744 -749.
8Agnelli G, Gallus A, Goldhaber SZ, et al. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban ( BAY 59-7939 ) : the ODIXa-13VT (oral direct factor Ya inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study[ J]. Circulation, 2007, 116(2) : 180 - 187.
9Campbell IA, Bentley DP, Prescott R J, et al. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial[ J]. BMJ, 2007, 334 (7595) :674.
10Yoshida M, lnoue I, Kawagoe T, et al. Novel percutaneous catheter thrombectomy in acute massive pulmonary embolism: rotational bidi- rectional thrombcctomy (ROBOT) [ J ]. Catheter Cardiovasc Inerv, 2006, 68(1 ) :112 - 117.
